In another study using the UPT method, histone deacetylase 2 (HDAC2) and prohibitin 2 (PHB2) were identified as targets of spiro [pyrrolidine-3,3'-oxindole], a potential anti-breast cancer compound 123. Here, PHB2 is linked to breast carcinoma.